Showing 20 of 83 recruiting trials for “Glioblastoma”
Glutamate Inhibitors in Glioblastoma
👨⚕️ Hans-Georg Wirsching, MD, University Hospital and University of Zurich📍 1 site📅 Started Jan 2023View details ↗
RecruitingNCT06146725 ↗
The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
RecruitingNCT06273176 ↗
The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
UNITy-BasED MR-Linac Adaptive Simultaneous Integrated Hypofractionated Boost Trial for High Grade Glioma in the Elderly
Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma Multiforme
A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
Glioblastoma Targeted Treatment Option Maximization by WGS
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
👨⚕️ John Boockvar, MD, Feinstein Institute for Medical Research/Lenox Hill Hospital📍 1 site📅 Started Apr 2022View details ↗
RecruitingNCT06118723 ↗
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumour Homogenate in Glioblastoma
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults
👨⚕️ Tom Davidson (tdavidson@chla.usc.edu), MD, Children's Hospital Los Angeles📍 20 sites📅 Started Oct 2020View details ↗
Peposertib and Radiation Therapy, Followed by Temozolomide for the Treatment of Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma or Gliosarcoma
Advanced MR Imaging as Predictor of Treatment Response in Newly Diagnosed Glioblastomas
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Study of Prognostic Biomarkers of Survival at 6 Months for Patients Treated With Bevacizumab Glioblastomas in First Relapse After Failure of Radiochemotherapy
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
👨⚕️ Francisco Diaz-Mitoma, MD, Variation Biotechnologies Inc.📍 12 sites📅 Started Dec 2017View details ↗
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
👨⚕️ John Boockvar, MD, Lenox Hill Hospital-Northwell Health📍 1 site📅 Started Jun 2017View details ↗
Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme
👨⚕️ Lung-Ji Chang, PhD, Shenzhen Geno-Immune Medical Institute📍 1 site📅 Started May 2017View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →